Caressa Lietman

1.2k total citations
19 papers, 910 citations indexed

About

Caressa Lietman is a scholar working on Genetics, Rheumatology and Cancer Research. According to data from OpenAlex, Caressa Lietman has authored 19 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 8 papers in Rheumatology and 7 papers in Cancer Research. Recurrent topics in Caressa Lietman's work include Connective tissue disorders research (12 papers), Protease and Inhibitor Mechanisms (7 papers) and Bone and Dental Protein Studies (7 papers). Caressa Lietman is often cited by papers focused on Connective tissue disorders research (12 papers), Protease and Inhibitor Mechanisms (7 papers) and Bone and Dental Protein Studies (7 papers). Caressa Lietman collaborates with scholars based in United States, United Kingdom and Canada. Caressa Lietman's co-authors include Brendan Lee, Terry Bertin, Erica P. Homan, Brian Dawson, Ingo Grafe, David R. Eyre, Elda Munivez, Mary Ann Weis, Yuqing Chen and Ming Jiang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Caressa Lietman

19 papers receiving 906 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caressa Lietman United States 14 521 391 389 160 143 19 910
MaryAnn Weis United States 10 581 1.1× 331 0.8× 324 0.8× 131 0.8× 141 1.0× 11 841
Shawna M. Pyott United States 9 546 1.0× 263 0.7× 295 0.8× 121 0.8× 104 0.7× 9 789
Dobrawa Napierala United States 15 385 0.7× 437 1.1× 299 0.8× 158 1.0× 179 1.3× 29 898
Laura Tonachini Italy 12 382 0.7× 282 0.7× 230 0.6× 111 0.7× 131 0.9× 18 746
Thomas E. Uveges United States 9 413 0.8× 190 0.5× 199 0.5× 106 0.7× 69 0.5× 9 670
Benjamin P. Sinder United States 16 247 0.5× 330 0.8× 170 0.4× 216 1.4× 66 0.5× 23 856
Joohyun Lim United States 13 233 0.4× 524 1.3× 143 0.4× 160 1.0× 147 1.0× 14 782
Els Van Hul Belgium 9 251 0.5× 536 1.4× 153 0.4× 222 1.4× 51 0.4× 15 739
V. Stănescu France 21 412 0.8× 375 1.0× 435 1.1× 125 0.8× 62 0.4× 61 968
Hadil Al‐Jallad Canada 12 254 0.5× 162 0.4× 161 0.4× 81 0.5× 47 0.3× 18 579

Countries citing papers authored by Caressa Lietman

Since Specialization
Citations

This map shows the geographic impact of Caressa Lietman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caressa Lietman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caressa Lietman more than expected).

Fields of papers citing papers by Caressa Lietman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caressa Lietman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caressa Lietman. The network helps show where Caressa Lietman may publish in the future.

Co-authorship network of co-authors of Caressa Lietman

This figure shows the co-authorship network connecting the top 25 collaborators of Caressa Lietman. A scholar is included among the top collaborators of Caressa Lietman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caressa Lietman. Caressa Lietman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lietman, Caressa & Meredith McKean. (2022). Targeting GNAQ/11 through PKC inhibition in uveal melanoma. Cancer Gene Therapy. 29(12). 1809–1813. 13 indexed citations
2.
Lietman, Caressa, Melissa L. Johnson, Frank McCormick, & Colin R. Lindsay. (2022). More to the RAS Story: KRASG12C Inhibition, Resistance Mechanisms, and Moving Beyond KRASG12C. American Society of Clinical Oncology Educational Book. 42(42). 205–217. 25 indexed citations
3.
Reichstein, David A., et al.. (2022). Treatment of metastatic uveal melanoma in 2022: improved treatment regimens and improved prognosis. Current Opinion in Ophthalmology. 33(6). 585–590. 7 indexed citations
4.
Lim, Joohyun, Caressa Lietman, Matthew W. Grol, et al.. (2021). Localized chondro-ossification underlies joint dysfunction and motor deficits in the Fkbp10 mouse model of osteogenesis imperfecta. Proceedings of the National Academy of Sciences. 118(25). 7 indexed citations
5.
Knüppel, Larissa, Juliane Merl‐Pham, Caressa Lietman, et al.. (2021). Prolyl-3-hydroxylase 4 (P3H4), a novel player in collagen synthesis and secretion in lung fibroblasts. PA3283–PA3283. 2 indexed citations
6.
Saraswati, Sarika, Caressa Lietman, Bin Li, et al.. (2020). Small proline‐rich repeat 3 is a novel coordinator of PDGFRβ and integrin β1 crosstalk to augment proliferation and matrix synthesis by cardiac fibroblasts. The FASEB Journal. 34(6). 7885–7904. 17 indexed citations
7.
Bendell, Johanna C., Ivor Percent, Robert Weaver, et al.. (2020). A phase II study of nab-paclitaxel plus ramucirumab for the second-line treatment of patients with metastatic gastroesophageal cancer.. Journal of Clinical Oncology. 38(4_suppl). 365–365. 3 indexed citations
8.
Lietman, Caressa, Brian Wu, Sarah Lechner, et al.. (2018). Inhibition of Wnt/β-catenin signaling ameliorates osteoarthritis in a murine model of experimental osteoarthritis. JCI Insight. 3(3). 140 indexed citations
9.
Durán, Iván, Jorge Martı́n, Mary Ann Weis, et al.. (2017). A Chaperone Complex Formed by HSP47, FKBP65, and BiP Modulates Telopeptide Lysyl Hydroxylation of Type I Procollagen. Journal of Bone and Mineral Research. 32(6). 1309–1319. 56 indexed citations
10.
Lietman, Caressa, Joohyun Lim, Ingo Grafe, et al.. (2017). Fkbp10 Deletion in Osteoblasts Leads to Qualitative Defects in Bone. Journal of Bone and Mineral Research. 32(6). 1354–1367. 18 indexed citations
11.
Lietman, Caressa, Bin Li, Sergio Fazio, et al.. (2017). Loss of SPRR3 in ApoE-/- mice leads to atheroma vulnerability through Akt dependent and independent effects in VSMCs. PLoS ONE. 12(9). e0184620–e0184620. 1 indexed citations
12.
Grafe, Ingo, Stefanie Alexander, Tao Yang, et al.. (2015). Sclerostin Antibody Treatment Improves the Bone Phenotype of Crtap–/– Mice, a Model of Recessive Osteogenesis Imperfecta. Journal of Bone and Mineral Research. 31(5). 1030–1040. 69 indexed citations
13.
Lietman, Caressa, Abbhirami Rajagopal, Erica P. Homan, et al.. (2014). Connective tissue alterations in Fkbp10−/− mice. Human Molecular Genetics. 23(18). 4822–4831. 48 indexed citations
14.
Lietman, Caressa, Ronit Marom, Elda Munivez, et al.. (2014). A Transgenic Mouse Model of OI Type V Supports a Neomorphic Mechanism of the IFITM5 Mutation. Journal of Bone and Mineral Research. 30(3). 489–498. 29 indexed citations
15.
Grafe, Ingo, Tao Yang, Stefanie Alexander, et al.. (2014). Excessive transforming growth factor-β signaling is a common mechanism in osteogenesis imperfecta. Nature Medicine. 20(6). 670–675. 229 indexed citations
16.
Homan, Erica P., Caressa Lietman, Ingo Grafe, et al.. (2014). Differential Effects of Collagen Prolyl 3-Hydroxylation on Skeletal Tissues. PLoS Genetics. 10(1). e1004121–e1004121. 28 indexed citations
17.
Grover, Monica, Philippe M. Campeau, Caressa Lietman, et al.. (2013). Osteogenesis imperfecta without features of type V caused by a mutation in the IFITM 5 gene. Journal of Bone and Mineral Research. 28(11). 2333–2337. 22 indexed citations
18.
Shapiro, Jay R., Caressa Lietman, Monica Grover, et al.. (2013). Phenotypic Variability of Osteogenesis Imperfecta Type V Caused by an IFITM 5 Mutation. Journal of Bone and Mineral Research. 28(7). 1523–1530. 61 indexed citations
19.
Homan, Erica P., Frank Rauch, Ingo Grafe, et al.. (2011). Mutations in SERPINF1 cause osteogenesis imperfecta type VI. Journal of Bone and Mineral Research. 26(12). 2798–2803. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by MaryAnn Weis Breakdown of academic impact, for papers by Shawna M. Pyott Breakdown of academic impact, for papers by Dobrawa Napierala Breakdown of academic impact, for papers by Laura Tonachini Breakdown of academic impact, for papers by Thomas E. Uveges Breakdown of academic impact, for papers by Benjamin P. Sinder Breakdown of academic impact, for papers by Joohyun Lim Breakdown of academic impact, for papers by Els Van Hul Breakdown of academic impact, for papers by V. Stănescu Breakdown of academic impact, for papers by Hadil Al‐Jallad
Rankless by CCL
2026